Banco de Sabadell’s Biogen BIIB Stock Holding History

Banco de Sabadell’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,113	Closed	-$3.46M	–	347
2020 Q2	$3.46M	Sell	13,113 -3,630	-22%	-$1.09M	0.45%	67
2020 Q1	$5.26M	Sell	16,743 -3,653	-18%	-$1.11M	0.83%	33
2019 Q4	$6.04M	Buy	+20,396	New	+$5.66M	0.8%	31
2019 Q3	–	Sell	-24,008	Closed	-$5.62M	–	335
2019 Q2	$5.62M	Buy	+24,008	New	+$5.54M	0.65%	43
2019 Q1	–	Sell	-27,368	Closed	-$8.13M	–	350
2018 Q4	$8.13M	Buy	27,368 +6,730	+33%	+$2.15M	0.99%	27
2018 Q3	$7.32M	Sell	20,638 -4,315	-17%	-$1.49M	0.8%	36
2018 Q2	$7.22M	Buy	24,953 +543	+2%	+$153K	0.92%	25
2018 Q1	$6.55M	Buy	24,410 +2,244	+10%	+$697K	0.79%	30
2017 Q4	$7.06M	Buy	+22,166	New	+$7.11M	0.91%	25

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Banco de Sabadell's BIIB Position: Q3 2020 in Review

Banco de Sabadell sold out of Biogen (BIIB) in Q3 2020, closing a stake of 13,113 shares — an estimated $3.46M sold.

Banco de Sabadell first reported a position in BIIB in Q4 2017 and held it in 9 quarters. The position peaked at $8.13M in Q4 2018. 1,052 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

Banco de Sabadell reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
Banco de Sabadell sold 13,113 Biogen shares in Q3 2020, an estimated $3.46M.
Banco de Sabadell first reported a position in Biogen in Q4 2017 and held it in 9 quarters.
Banco de Sabadell's Biogen position peaked at $8.13M in Q4 2018.
1,052 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Banco de Sabadell's 13F filing for Q3 2020, filed 13 Nov 2020.